Traws Pharma
TRAW
TRAW
30 hedge funds and large institutions have $3.61M invested in Traws Pharma in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
41% less capital invested
Capital invested by funds: $6.14M → $3.61M (-$2.53M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
30
Holding in Top 10
–
Calls
$32K
Puts
$8K
Top Buyers
| 1 | +$346K | |
| 2 | +$105K | |
| 3 | +$50.6K | |
| 4 |
Millennium Management
New York
|
+$19.3K |
| 5 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$12K |
Top Sellers
| 1 | -$668K | |
| 2 | -$370K | |
| 3 | -$232K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$147K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$104K |